Results 241 to 250 of about 117,898 (292)

Imatinib: A Promising Therapeutic Shining Light on Pulmonary Arterial Hypertension Treatment

Yutong Ding, Yuting Zhang, Xiaofen Su, Yanjuan Wu, Nuofu Zhang, Kang Wu   +5 more
openalex   +2 more sources

Cytogenetic profile of chronic myeloid leukaemia patients resistant to imatinib at tertiary level in Indonesia. [PDF]

Mol Cytogenet
Rinaldi I, Louisa M, Arwanih EY, Adibah FF, Kadharusman MM, Remifta Putra MA, Winston K, Shufiyani YM, Salma RA.   +8 more
europepmc   +1 more source

An incidental finding of duodenal gastrointestinal stromal tumor (dGIST): a case report. [PDF]

Ann Med Surg (Lond)
Nazir A, Rehman NK, Khalid F, Arshad A.
europepmc   +1 more source

Chronic Disseminated Intravascular Coagulation in Patient With Metastatic Gastrointestinal Stromal Tumor: Treating Bleeding With Anticoagulation. [PDF]

J Med Cases
Bopp E, Cui Z, Elkon J.
europepmc   +1 more source

Treatment Cessation in Chronic Myeloid Leukemia: Evidence and Uncertainties. [PDF]

Hematol Oncol
Mayer J.
europepmc   +1 more source

KIT-Mutant Melanoma: Understanding the Pathway to Personalized Therapy. [PDF]

Cancers (Basel)
Kaveti A, Sullivan RJ, Tsao H.
europepmc   +1 more source

The role of the lysine histone methylase KMT2D in chronic myeloid leukemia. [PDF]

Front Pharmacol
Schlemminger L, Nagel I, Vater I, Cascorbi I, Kaehler M.   +4 more
europepmc   +1 more source

Targeting Inflammation: Cytosporone B Modulates Imatinib-Driven Biochemical Alterations in Rat Heart. [PDF]

Int J Mol Sci
Börzsei D, Nagy A, Kiss V, Virág Z, Kis G, Almási N, Török S, Veszelka M, Varga C, Szabó R.   +9 more
europepmc   +1 more source

Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cells. [PDF]

Gastric Cancer
Yokouchi T, Takahashi T, Nishida T, Tanaka K, Kurokawa Y, Yamamoto K, Saito T, Hagi T, Momose K, Yamashita K, Makino T, Kawai K, Serada S, Fujimoto M, Hirota S, Nakajima K, Naka T, Eguchi H, Doki Y.   +18 more
europepmc   +1 more source

BCR-ABL tyrosine kinase inhibitors associated acute kidney injury: a pharmacovigilance study based on the FAERS database with a case report. [PDF]

BMC Nephrol
Shi Y, Deng L, Zhu J, Huang Y, Zeng M, Mao H, Huang Z, Wu B.   +7 more
europepmc   +1 more source